| AD | Alzheimer’s Disease |
| AD-CL | Alzheimer’s Disease Cluster |
| fAD | Familiar Alzheimer’s Disease |
| sAD | Sporadic Alzheimer’s Disease |
| Aβ | Amyloid-beta |
| Aβi | Amyloid-beta insoluble |
| Aβs | Amyloid-beta soluble |
| APP | Amyloid Precursor Protein |
| CAA | Cerebral Amyloid Angiopathy |
| CNS | Central Nervous System |
| CD14 | Cluster Differentiation 14 |
| CCL | Chemokine (C-C motif) ligand |
| CXCL | Chemokine (C-X-C motif) ligand |
| CX3CL | Chemokine (C-X3-C motif) ligand |
| DI | Dispersion index |
| HCA | Hierarchical Cluster Analysis |
| IFN-γ | Interferon-gamma |
| IHC | Immunohistochemistry |
| IIF | Innate immunity Factor |
| IL | Interleukin |
| IL-1rn | Interleukin-1 receptor antagonist |
| LCN2 | Lipocalin-2 |
| LPS | Lipopolysaccharides |
| MMP | Matrix Metalloproteinase |
| MS | Multiple Sclerosis |
| OOR | Out of range |
| p-tau | Hyper-phosphorylated tau |
| PS1 | Presenilin-1 |
| PPI | Protein-Protein Interaction |
| TNFα | Tumor necrosis factor-alpha |